• Home
  • NEW DAY MEDICINE
  • 7 (81) 2025
  • 98 -7 (81) 2025 - Raimova M.M., Mukhamedsaidova I.A. - CLINICAL AND BIOCHEMICAL FEATURES AND TREATMENT ASPECTS OF RESTLESS LEGS SYNDROME IN THE CONTEXT OF DIABETES MELLITUS

98 -7 (81) 2025 - Raimova M.M., Mukhamedsaidova I.A. - CLINICAL AND BIOCHEMICAL FEATURES AND TREATMENT ASPECTS OF RESTLESS LEGS SYNDROME IN THE CONTEXT OF DIABETES MELLITUS

CLINICAL AND BIOCHEMICAL FEATURES AND TREATMENT ASPECTS OF RESTLESS LEGS SYNDROME IN THE CONTEXT OF DIABETES MELLITUS

Raimova M.M. - Tashkent State Medical University

Mukhamedsaidova I.A. - Tashkent State Medical University

Resume

Restless legs syndrome observed in diabetes mellitus is a relevant clinical issue at the intersection of neurology and endocrinology. It is a neurological condition that arises as a complication of diabetes mellitus, primarily due to peripheral nerve damage in the lower limbs. This article provides a comprehensive overview of early diagnosis, proper differentiation, and the implementation of individualized treatment strategies for patients with diabetes suffering from restless legs syndrome. The study emphasizes that timely identification and appropriate management of this condition can improve the prognosis of disease progression, prevent complications, and enhance patients’ quality of life

Keywords: diabetes mellitus, secondary restless legs syndrome, homocysteine, melatonin, cystatin C, electroneuromyography, diabetic polyneuropathy

First page

522

Last page

525

For citation:Raimova M.M., Mukhamedsaidova I.A. - CLINICAL AND BIOCHEMICAL FEATURES AND TREATMENT ASPECTS OF RESTLESS LEGS SYNDROME IN THE CONTEXT OF DIABETES MELLITUS//New Day in Medicine 7(81)2025 522-525 https://newdayworldmedicine.com/en/new_day_medicine/7-81-2025

List of References

  1. Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance. Sleep Medicine, 2014;15(8):860-873.
  2. Garcia-Malo C., et al.Restless Legs Syndrome - Clinical Features. PubMed, 2021.
  3. Gossard T.R., Trotti L.M., Videnovic A., St Louis E.K. Restless legs syndrome: Contemporary diagnosis and treatment. Neurotherapeutics, 2021, 18 (1), 140–155.
  4. Ming Yang Tang, Jingqing Sun, Yanan Zhang Dopaminergic dysfunction and restless legs syndrome: The role of iron. Neurochemical Research, 2023;44(5): 1209-1218.
  5. Manconi M, Ferri R. Iron metabolism and restless legs syndrome. Sleep Medicine Clinics, 2021;16(1):69-80.
  6. New insights into diabetes mellitus and its complications: a narrative review. Department of Endocrinology, the Third Affiliated Hospital of Soochow University, Changzhou, China Prof. Fei Hua, MD, PhD Email: czhuafei@vip.sina.com Accepted 2020 Dec 16; Issue date 2020 Dec.
  7. Raimova M.M., Mukhamedsaidova I.A. Restless legs syndrome in the context of chronic kidney disease. (Clinical case) Central Asian Journal of Medicine. № 6, 2025. Vol. 1 P. 86-89
  8. Trenkwalder C, Allen R, Högl B, et al. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurology, 2018;17(11):994-1005.
  9. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study identifies novel risk loci for restless legs syndrome. Nature Communications, 2017;8: 141.
  10. Алексеева Н.С., Козлов В.А. Клинические и биохимические особенности синдрома беспокойных ног у пожилых пациентов. Вестник клинической медицины, 2022, №2

    file

    download